Literature DB >> 10431157

CD26, let it cut or cut it down.

I De Meester1, S Korom, J Van Damme, S Scharpé.   

Abstract

The costimulatory properties of CD26 have been studied extensively and significant progress has been made in unravelling the complex nature of this molecule. Here, we summarize recent findings on molecular and functional characteristics of CD26. We argue that a multidisciplinary approach might reveal the molecular events underlying the role of CD26 in HIV infection and immune, inflammatory and endocrine responses.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10431157     DOI： 10.1016/s0167-5699(99)01486-3

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


  98 in total

Review 1.  Promising new approaches to the management of obesity.

Authors:  I L Mertens; L F Van Gaal
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

Review 2.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

3.  Glycine-amide is an active metabolite of the antiretroviral tripeptide glycyl-prolyl-glycine-amide.

Authors:  Elin Andersson; Peter Horal; Alenka Jejcic; Stefan Höglund; Jan Balzarini; Anders Vahlne; Bo Svennerholm
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

4.  Interleukin-16 as a marker of Sézary syndrome onset and stage.

Authors:  Jillian Richmond; Marina Tuzova; Ashley Parks; Natalie Adams; Elizabeth Martin; Marianne Tawa; Lynne Morrison; Keri Chaney; Thomas S Kupper; Clara Curiel-Lewandrowski; William Cruikshank
Journal:  J Clin Immunol       Date:  2010-09-28       Impact factor: 8.317

Review 5.  Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.

Authors:  C Klemann; L Wagner; M Stephan; S von Hörsten
Journal:  Clin Exp Immunol       Date:  2016-05-13       Impact factor: 4.330

6.  Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26.

Authors:  D Marguet; L Baggio; T Kobayashi; A M Bernard; M Pierres; P F Nielsen; U Ribel; T Watanabe; D J Drucker; N Wagtmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

7.  Expression of T lymphocyte chemoattractants and activation markers in vernal keratoconjunctivitis.

Authors:  A M Abu El-Asrar; S Struyf; S A Al-Kharashi; L Missotten; J Van Damme; K Geboes
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

8.  Protection of glucagon-like peptide-1 in cisplatin-induced renal injury elucidates gut-kidney connection.

Authors:  Daisuke Katagiri; Yoshifumi Hamasaki; Kent Doi; Koji Okamoto; Kousuke Negishi; Masaomi Nangaku; Eisei Noiri
Journal:  J Am Soc Nephrol       Date:  2013-10-03       Impact factor: 10.121

9.  DPP-4 Inhibition Leads to Decreased Pancreatic Inflammatory Profile and Increased Frequency of Regulatory T Cells in Experimental Type 1 Diabetes.

Authors:  Mariana Rodrigues Davanso; Carolina Caliari-Oliveira; Carlos Eduardo Barra Couri; Dimas Tadeu Covas; Angela Merice de Oliveira Leal; Júlio César Voltarelli; Kelen Cristina Ribeiro Malmegrim; Juliana Navarro Ueda Yaochite
Journal:  Inflammation       Date:  2019-04       Impact factor: 4.092

Review 10.  A review of the efficacy and safety of oral antidiabetic drugs.

Authors:  Stephanie Aleskow Stein; Elizabeth Mary Lamos; Stephen N Davis
Journal:  Expert Opin Drug Saf       Date:  2012-12-14       Impact factor: 4.250
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.